At a glance
- Originator Taisho Pharmaceutical
- Class Anti-ischaemics; Antihypertensives; Vascular disorder therapies; Vasodilators
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Angina pectoris; Hypertension
Most Recent Events
- 23 Jun 1995 Discontinued-II for Angina pectoris in Japan (PO)
- 23 Jun 1995 Discontinued-II for Hypertension in Japan (PO)